FDA Adverse Event Injury Summary report: N

CAPSUREFIX NOVUS MRI

MDR report key: 2131916 · Received June 16, 2011

Report

Report Number
2649622-2011-10593
Event Type
Injury
Date Received
June 16, 2011
Date of Event
April 29, 2011
Manufacturer
MEDTRONIC PUERTO RICO, INC.
Product Code
NVN
PMA / PMN Number
P090013
Removal / Correction Number
ASKU
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. EVALUATION SUMMARY: (B)(4): THE FULL LEAD WAS RETURNED, ANALYZED AND THE OUTER INSULATION WAS BREACHED CUT. IT WAS NOTED THAT THE PROXIMAL CONDUCTOR WAS DISTORTED, THERE WAS BLOOD/BODY FLUID ON THE PROXIMAL CONDUCTOR (NOT OBSTRUCTED), THERE WAS BLOOD IN/ON THE HELIX MECHANISM AND THE LEAD APPEARED DAMAGED AT IMPLANT. (B)(4): THE FULL LEAD WAS RETURNED, ANALYZED AND THE OUTER INSULATION WAS BREACHED CUT. IT WAS NOTED THAT THERE WAS BLOOD/BODY FLUID ON THE PROXIMAL CONDUCTOR (NOT OBSTRUCTED), THERE WAS BLOOD IN/ON THE HELIX MECHANISM AND THE LEAD APPEARED DAMAGED AT IMPLANT.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING IMPLANT OF THE VENTRICULAR LEAD THE DOCTOR ATTEMPTED TO PEEL BACK THE SHEATH WHICH CAUSED THE HAEMOSTATIC VALVE TO COMPLETELY TEAR AWAY FROM THE SHEATH BODY WITH THE LEAD RETAINED IN THE INNER LUMEN. THE PHYSICIAN HAD TO FURTHER DISSECT THE POCKET TO RETRIEVE THE SHEATH BODY AND THERE WAS DAMAGE TO THE LEAD IN THE PROCESS, WITH VISIBLE BREAK IN INSULATION. THEREFORE ANOTHER LEAD WAS PLACED, HOWEVER WITH THE SAME RESULTS. BOTH LEADS WERE DISCARDED AND A DIFFERENT LEAD IMPLANTED. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CAPSUREFIX NOVUS MRI IMPLANTABLE PACING LEAD NVN MEDTRONIC PUERTO RICO, INC. 5086MRI ASKU

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention